Sunhawk Vision Biotech (7759) Stock Overview
Operates as a drug development company that develops microRNA therapeutic eye drops. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
7759 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sunhawk Vision Biotech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$33.40 |
| 52 Week High | NT$89.90 |
| 52 Week Low | NT$32.05 |
| Beta | 0 |
| 1 Month Change | -15.44% |
| 3 Month Change | -21.23% |
| 1 Year Change | -53.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -68.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7759 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -10.0% | -3.0% | 5.7% |
| 1Y | -53.3% | -7.7% | 108.5% |
Return vs Industry: 7759 underperformed the TW Pharmaceuticals industry which returned -7.7% over the past year.
Return vs Market: 7759 underperformed the TW Market which returned 108.5% over the past year.
Price Volatility
| 7759 volatility | |
|---|---|
| 7759 Average Weekly Movement | 17.2% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in TW Market | 12.3% |
| 10% least volatile stocks in TW Market | 2.5% |
Stable Share Price: 7759's share price has been volatile over the past 3 months compared to the TW market.
Volatility Over Time: 7759's weekly volatility has increased from 11% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | n/a | www.sunhawkvision.com |
Sunhawk Vision Biotech, Inc. operates as a drug development company that develops microRNA therapeutic eye drops. Its flagship product is SHJ002 eye drops. Sunhawk Vision Biotech, Inc. was founded in 2019 and is based in Taipei, Taiwan.
Sunhawk Vision Biotech, Inc. Fundamentals Summary
| 7759 fundamental statistics | |
|---|---|
| Market cap | NT$2.34b |
| Earnings (TTM) | -NT$172.39m |
| Revenue (TTM) | n/a |
Is 7759 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7759 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$172.39m |
| Earnings | -NT$172.39m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.46 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did 7759 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/31 00:03 |
| End of Day Share Price | 2026/05/29 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sunhawk Vision Biotech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.